Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4603870 | 0.82 | — | — | |
| SCHEMBL200330 | 0.81 | KDM4E (0.32) | ALDH1A1 | |
| SCHEMBL31345606 | 0.78 | KDM4E (0.33) | ALDH1A1 | |
| SCHEMBL1077813 | 0.78 | KDM4E (0.33) | ALDH1A1 | |
| SCHEMBL200220 | 0.77 | KDM4E (0.32) | ALDH1A1 | |
| SCHEMBL4787655 | 0.75 | KDM4E (0.30) | ALDH1A1 | |
| SCHEMBL6422416 | 0.73 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL17121959 | 0.72 | KDM4E (0.34) | ALDH1A1 | |
| SCHEMBL4604162 | 0.71 | KDM4E (0.30) | ALDH1A1 | |
| SCHEMBL203038 | 0.70 | KDM4E (0.38) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 254 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12629657-B2 | Lithium ion adsorbents | EMPOWER INNOVATION & TECHNOLOGY LLC (US) | 2026-05-19 | — | — | US | claimed |
| WO-2024107042-A1 | SILANE COMPOUND AND COMPOSITIONS CONTAINING SAME | SYNTHOMER SDN BHD (MY) | 2024-05-23 | — | — | WO | claimed |
| EP-4308613-A1 | POLYMER LATEX COMPOSITION | Synthomer Sdn. Bhd. (MY) | 2024-01-24 | — | — | EP | claimed |
| EP-4223409-A1 | LITHIUM ION ADSORBENTS | Conductive Energy Inc. (CA) | 2023-08-09 | — | — | EP | claimed |
| US-20230241581-A1 | LITHIUM ION ADSORBENTS | CONDUCTIVE ENERGY INC. (CA) | 2023-08-03 | — | — | US | claimed |
| US-11667969-B2 | Protective surface coatings for flow cells | ILLUMINA, INC. (US) | 2023-06-06 | — | — | US | claimed |
| WO-2022197175-A1 | POLYMER LATEX COMPOSITION | SYNTHOMER SDN BHD (MY) | 2022-09-22 | — | — | WO | claimed |
| US-12629657-B2 | Lithium ion adsorbents | EMPOWER INNOVATION & TECHNOLOGY LLC (US) | 2026-05-19 | — | — | US | disclosed |
| US-20260125513-A1 | CURABLE RESIN COMPOSITIONS | ILLUMINA INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260125753-A1 | PROTECTIVE SURFACE COATINGS FOR FLOW CELLS | ILLUMINA INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260117218-A1 | CONTROLLED DNA FRAGMENT LENGTH BIAS FOR AMPLIFICATION | ILLUMINA INC (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4405750-B1 | CURABLE RESIN COMPOSITIONS | ILLUMINA INC (US) | 2026-04-22 | — | — | EP | disclosed |
| US-12584035-B2 | Flow cells | ILLUMINA, INC. (US) | 2026-03-24 | — | — | US | disclosed |
| US-20040063873-A1 | Processes for producing cycloolefin addition polymer | JSR CORPORATION (JP) | 2004-04-01 | — | — | US | disclosed |
| EP-1364975-A1 | PROCESSES FOR PRODUCING CYCLOOLEFIN ADDITION POLYMER | JSR Corporation (JP) | 2003-11-26 | — | — | EP | disclosed |
| US-6562908-B2 | Blend of rubber reinforced thermoplastic resins, acrylic resins and thermoplastic norbornene resins; heat resistance, strength, processability, and laser marking properties | JSR CORPORATION (JP) | 2003-05-13 | — | — | US | disclosed |
| US-20020128392-A1 | Thermoplastic resin composition and shaped articles thereof | JSR CORPORATION (JP) | 2002-09-12 | — | — | US | disclosed |
| EP-1223195-A2 | Thermoplastic resin composition and shaped articles thereof | JSR Corporation (JP) | 2002-07-17 | — | — | EP | disclosed |
| US-20020042461-A1 | Composition of cyclic olefin addition copolymer and cross-linked material | JSR CORPORATION (JP) | 2002-04-11 | — | — | US | disclosed |
| EP-1195397-A1 | Composition of cyclic olefin addition copolymer and cross-linked material | JSR Corporation (JP) | 2002-04-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629657-B2 | Lithium ion adsorbents | ILK, SDC1, LAMTOR3 | ALDH1A1 2379/4885 |
| US-20260117218-A1 | CONTROLLED DNA FRAGMENT LENGTH BIAS FOR AMPLIFICATION | POLL, POLB, DNMT3A | ALDH1A1 2848/4885 |
| US-12584035-B2 | Flow cells | MSR1, CCR7, CCR6 | ALDH1A1 1229/4885 |
| US-20260125753-A1 | PROTECTIVE SURFACE COATINGS FOR FLOW CELLS | CD74, CD44, EPCAM | ALDH1A1 960/4885 |
| US-20260125513-A1 | CURABLE RESIN COMPOSITIONS | RAD51, ACR, ACMSD | ALDH1A1 562/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.